601 related articles for article (PubMed ID: 34656480)
1. Hybrid Cardiac Magnetic Resonance/Fluorodeoxyglucose Positron Emission Tomography to Differentiate Active From Chronic Cardiac Sarcoidosis.
Greulich S; Gatidis S; Gräni C; Blankstein R; Glatthaar A; Mezger K; Müller KAL; Castor T; Mahrholdt H; Häntschel M; Hetzel J; Dittmann H; Nikolaou K; Gawaz M; la Fougère C; Krumm P
JACC Cardiovasc Imaging; 2022 Mar; 15(3):445-456. PubMed ID: 34656480
[TBL] [Abstract][Full Text] [Related]
2. Hybrid Magnetic Resonance Imaging and Positron Emission Tomography With Fluorodeoxyglucose to Diagnose Active Cardiac Sarcoidosis.
Dweck MR; Abgral R; Trivieri MG; Robson PM; Karakatsanis N; Mani V; Palmisano A; Miller MA; Lala A; Chang HL; Sanz J; Contreras J; Narula J; Fuster V; Padilla M; Fayad ZA; Kovacic JC
JACC Cardiovasc Imaging; 2018 Jan; 11(1):94-107. PubMed ID: 28624396
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic utility of fusion
Okune M; Yasuda M; Soejima N; Kagioka Y; Kakehi K; Kawamura T; Hanaoka K; Kaida H; Ishii K; Nakazawa G; Miyazaki S; Iwanaga Y
J Nucl Cardiol; 2022 Apr; 29(2):753-764. PubMed ID: 33000410
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of newly diagnosed sarcoidosis in patients with ventricular arrhythmias: a cardiac magnetic resonance and 18F-FDG cardiac PET study.
Kebed KY; Carter SV; Flatley E; Ward RP; Moss JD; Appelbaum DE; Singh A; Lang RM; Tung R; Patel AR
Int J Cardiovasc Imaging; 2021 Apr; 37(4):1361-1369. PubMed ID: 33225427
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in cardiac sarcoidosis.
Wicks EC; Menezes LJ; Barnes A; Mohiddin SA; Sekhri N; Porter JC; Booth HL; Garrett E; Patel RS; Pavlou M; Groves AM; Elliott PM
Eur Heart J Cardiovasc Imaging; 2018 Jul; 19(7):757-767. PubMed ID: 29319785
[TBL] [Abstract][Full Text] [Related]
6. Hybrid Magnetic Resonance Positron Emission Tomography Is Associated With Cardiac-Related Outcomes in Cardiac Sarcoidosis.
Trivieri MG; Robson PM; Vergani V; LaRocca G; Romero-Daza AM; Abgral R; Devesa A; Azoulay LD; Karakatsanis NA; Parikh A; Panagiota C; Palmisano A; DePalo L; Chang HL; Rothstein JH; Fayad RA; Miller MA; Fuster V; Narula J; Dweck MR; Morgenthau A; Jacobi A; Padilla M; Kovacic JC; Fayad ZA
JACC Cardiovasc Imaging; 2024 Apr; 17(4):411-424. PubMed ID: 38300202
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of cardiac sarcoidosis despite negative findings on serial late gadolinium enhancement with cardiac magnetic resonance imaging/
Tanaka TD; Nagai T; Nagoshi T; Yoshimura M
J Nucl Cardiol; 2020 Dec; 27(6):2149-2153. PubMed ID: 31773564
[TBL] [Abstract][Full Text] [Related]
8. Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis.
Ohira H; Birnie DH; Pena E; Bernick J; Mc Ardle B; Leung E; Wells GA; Yoshinaga K; Tsujino I; Sato T; Manabe O; Oyama-Manabe N; Nishimura M; Tamaki N; Dick A; Dennie C; Klein R; Renaud J; deKemp RA; Ruddy TD; Chow BJW; Davies R; Hessian R; Liu P; Beanlands RSB; Nery PB
Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):259-269. PubMed ID: 26359191
[TBL] [Abstract][Full Text] [Related]
9. Regional extracellular volume within late gadolinium enhancement-positive myocardium to differentiate cardiac sarcoidosis from myocarditis of other etiology: a cardiovascular magnetic resonance study.
Treiber J; Novak D; Fischer-Rasokat U; Wolter JS; Kriechbaum S; Weferling M; von Jeinsen B; Hain A; Rieth AJ; Siemons T; Keller T; Hamm CW; Rolf A
J Cardiovasc Magn Reson; 2023 Feb; 25(1):8. PubMed ID: 36755275
[TBL] [Abstract][Full Text] [Related]
10. Feasibility of FDG-PET in myocarditis: Comparison to CMR using integrated PET/MRI.
Nensa F; Kloth J; Tezgah E; Poeppel TD; Heusch P; Goebel J; Nassenstein K; Schlosser T
J Nucl Cardiol; 2018 Jun; 25(3):785-794. PubMed ID: 27638745
[TBL] [Abstract][Full Text] [Related]
11. Comparison of cardiac magnetic resonance imaging and fluorodeoxyglucose positron emission tomography in the assessment of cardiac sarcoidosis: Meta-analysis and systematic review.
Adhaduk M; Paudel B; Khalid MU; Ashwath M; Mansour S; Liu K
J Nucl Cardiol; 2023 Aug; 30(4):1574-1587. PubMed ID: 36443587
[TBL] [Abstract][Full Text] [Related]
12. Regional myocardial damage and active inflammation in patients with cardiac sarcoidosis detected by non-invasive multi-modal imaging.
Kataoka S; Momose M; Fukushima K; Serizawa N; Suzuki A; Kondo C; Abe K; Sakai S; Hagiwara N
Ann Nucl Med; 2017 Feb; 31(2):135-143. PubMed ID: 27804054
[TBL] [Abstract][Full Text] [Related]
13. Clinical Characteristics of Late Gadolinium Enhancement in Patients with Cardiac Sarcoidosis.
Matsumoto K; Ehara S; Sakaguchi M; Otsuka K; Hasegawa T; Shimada K; Yoshiyama M
Osaka City Med J; 2015 Jun; 61(1):9-17. PubMed ID: 26434101
[TBL] [Abstract][Full Text] [Related]
14. Complementary Value of Cardiac Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Assessment of Cardiac Sarcoidosis.
Vita T; Okada DR; Veillet-Chowdhury M; Bravo PE; Mullins E; Hulten E; Agrawal M; Madan R; Taqueti VR; Steigner M; Skali H; Kwong RY; Stewart GC; Dorbala S; Di Carli MF; Blankstein R
Circ Cardiovasc Imaging; 2018 Jan; 11(1):e007030. PubMed ID: 29335272
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of FDG PET combined with cardiac MRI for the diagnosis and therapeutic monitoring of cardiac sarcoidosis.
Sgard B; Brillet PY; Bouvry D; Djelbani S; Nunes H; Meune C; Valeyre D; Soussan M
Clin Radiol; 2019 Jan; 74(1):81.e9-81.e18. PubMed ID: 30482560
[TBL] [Abstract][Full Text] [Related]
16. Utility of Cardiac Magnetic Resonance Imaging Versus Cardiac Positron Emission Tomography for Risk Stratification for Ventricular Arrhythmias in Patients With Cardiac Sarcoidosis.
Gowani Z; Habibi M; Okada DR; Smith J; Derakhshan A; Zimmerman SL; Misra S; Gilotra NA; Berger RD; Calkins H; Tandri H; Chrispin J
Am J Cardiol; 2020 Nov; 134():123-129. PubMed ID: 32950203
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of cardiac sarcoidosis in patients presenting with cardiac arrest or life-threatening arrhythmias.
Hatipoglu S; Gardezi SKM; Azzu A; Baksi J; Alpendurada F; Izgi C; Khattar R; Kouranos V; Wells AU; Sharma R; Wechalekar K; Pennell DJ; Mohiaddin R
Heart; 2023 Apr; 109(10):748-755. PubMed ID: 36627181
[TBL] [Abstract][Full Text] [Related]
18. Risk assessment of patients with clinical manifestations of cardiac sarcoidosis with positron emission tomography and magnetic resonance imaging.
Bravo PE; Raghu G; Rosenthal DG; Elman S; Petek BJ; Soine LA; Maki JH; Branch KR; Masri SC; Patton KK; Caldwell JH; Krieger EV
Int J Cardiol; 2017 Aug; 241():457-462. PubMed ID: 28318664
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the Electroanatomic Substrate in Cardiac Sarcoidosis: Correlation With Imaging Findings of Scar and Inflammation.
Muser D; Santangeli P; Liang JJ; Castro SA; Magnani S; Hayashi T; Garcia FC; Frankel DS; Dixit S; Zado ES; Lin D; Desjardins B; Callans DJ; Alavi A; Marchlinski FE
JACC Clin Electrophysiol; 2018 Mar; 4(3):291-303. PubMed ID: 30089553
[TBL] [Abstract][Full Text] [Related]
20. The role of cardiac magnetic resonance in diagnosis of cardiac sarcoidosis.
Tadic M; Cuspidi C; Saeed S; Milojevic B; Milojevic IG
Heart Fail Rev; 2021 May; 26(3):653-660. PubMed ID: 33025413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
